These results are encouraging since impaired cathepsin L activity, either due to altered expression or the presence of inhibitor, has been implied in many diseases, including lysosomal storage disorders, osteoporosis, cancer, neurodegenerative disorders, and cardiovascular diseases [28–31]. Here, CTSL is linked to cancer.